Cargando…
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355696/ https://www.ncbi.nlm.nih.gov/pubmed/35936741 http://dx.doi.org/10.3389/fonc.2022.971042 |
| _version_ | 1784763353143443456 |
|---|---|
| author | de Marinis, Filippo Attili, Ilaria Gridelli, Cesare Cecere, Fabiana Curcio, Carlo Facciolo, Francesco Spaggiari, Lorenzo |
| author_facet | de Marinis, Filippo Attili, Ilaria Gridelli, Cesare Cecere, Fabiana Curcio, Carlo Facciolo, Francesco Spaggiari, Lorenzo |
| author_sort | de Marinis, Filippo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9355696 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93556962022-08-06 Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology de Marinis, Filippo Attili, Ilaria Gridelli, Cesare Cecere, Fabiana Curcio, Carlo Facciolo, Francesco Spaggiari, Lorenzo Front Oncol Oncology Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9355696/ /pubmed/35936741 http://dx.doi.org/10.3389/fonc.2022.971042 Text en Copyright © 2022 de Marinis, Attili, Gridelli, Cecere, Curcio, Facciolo and Spaggiari https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology de Marinis, Filippo Attili, Ilaria Gridelli, Cesare Cecere, Fabiana Curcio, Carlo Facciolo, Francesco Spaggiari, Lorenzo Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title | Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title_full | Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title_fullStr | Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title_full_unstemmed | Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title_short | Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology |
| title_sort | incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by italian association of thoracic oncology |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355696/ https://www.ncbi.nlm.nih.gov/pubmed/35936741 http://dx.doi.org/10.3389/fonc.2022.971042 |
| work_keys_str_mv | AT demarinisfilippo incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT attiliilaria incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT gridellicesare incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT cecerefabiana incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT curciocarlo incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT facciolofrancesco incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology AT spaggiarilorenzo incorporatingatezolizumabintheadjuvantsettingofnonsmallcelllungcancerkeydiscussionpointsfromanexpertmultidisciplinarypanelbyitalianassociationofthoraciconcology |